Form 4: Know Labs Director John Cronin Acquires Shares

Director John Cronin reports acquisition of Know Labs shares both directly and indirectly through ipCapital Group, Inc.

Summary

• On May 5, 2025, John Cronin, a director of Know Labs, Inc., acquired 25,000 shares of common stock directly at a price of $0.44 per share.
• On the same day, Cronin also acquired 25,000 shares of common stock indirectly through ipCapital Group, Inc. at $0.44 per share.
• Following these transactions, Cronin directly owns 25,404 shares and indirectly owns 25,000 shares through ipCapital Group, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. The purchase itself could be seen as slightly positive, but the filing is simply a procedural requirement.

Positives

• The director's purchase of shares may signal confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The director's purchase could be viewed positively by shareholders, potentially increasing investor confidence.

Key Dates

Keywords

Know Labs, John Cronin, share acquisition, director, Form 4, ipCapital Group, KNW